Cozy 🛰️ 🏴‍☠️

$HYFT MindWalk Announces Agreement with Teva Australia to Support Defined Antibody-Discovery Workflows November 4, 2026 Multi-year agreement covers a defined deployment of ReefIQ™ and specified LensAI™ capabilities AUSTIN, Texas--(BUSINESS WIRE)-- MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today announced a multi-year agreement with Teva Pharmaceuticals Australia Pty Ltd (“Teva Australia”) to deploy ReefIQ™, MindWalk’s HYFT®-powered biological context layer with specified LensAI™ analytical capabilities, in support of a defined scope of antibody-discovery work. Teva Australia will use the AI capabilities to support discovery decisions based on generated predictions and accelerate antibody design optimization. MindWalk has been collaborating with Teva Australia since 2018. “We are pleased to continue our collaboration with Teva Australia through this defined deployment,” said Jennifer Bath, PhD, President and Chief Executive Officer of MindWalk.“Across the industry, the constraint in antibody discovery is no longer generating data. It is connecting and governing that data and carrying what a program team learns to the next phase. That is exactly what ReefIQ was built to do for companies.” Under the agreement, MindWalk will provide authorized analysis of approved data sources within the agreed scope. Deployment and use will be subject to Teva Australia’s applicable information-security, privacy, data-governance, scientific-review and human-oversight requirements. Financial terms were not disclosed. “The power of AI in drug discovery is not in generating more possibilities, it’s about helping scientists find the ones that matter. By pairing computational insight with deep biological expertise and experimental validation, we can make smarter decisions earlier and focus on antibodies with the greatest potential to become meaningful medicines,” said Anthony Doyle, Vice President, Antibody Discovery at Teva Australia. For MindWalk, the agreement is the kind of recurring-revenue platform relationship the company told the market to expect. A fee-for-service project ends when the deliverable is shipped, and a conventional software subscription is priced by the seat. A ReefIQ deployment is different on both counts: it is a multi-year platform relationship with recurring revenue, supporting scientists as programs advance within the agreed scope and under each company’s data-governance requirements. MindWalk is in active discussions with additional life sciences organizations regarding ReefIQ deployments. About ReefIQ™ ReefIQ™ is MindWalk’s biological context layer for life sciences, powered by HYFT® Technology. HYFT provides the underlying biological representation: 660 million biological patterns and 25 billion relationships refined over 20 years of curation. ReefIQ organizes and governs connected biological context drawn from agreed sources, including sequences, structures, assay outputs, literature, evidence, provenance, and program history. LensAI™, MindWalk’s reasoning and application layer, and client selected models or agents operate over that context, subject to each client’s integration, deployment, governance, and human-review requirements. As new data and relationships are added, updated context becomes available under the client’s governance, and prior positive and negative results remain queryable where authorized. AI models turn over; the context layer accumulates.